Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells
March 8th, 2019
7.7K views
This protocol demonstrates how to purify extracellular microRNAs from cell culture media for small RNA library construction and next generation sequencing. Various quality control checkpoints are described to allow readers to understand what to expect when working with low input samples like exRNAs.
Overview
This protocol demonstrates how to purify extracellular microRNAs from cell culture media for small RNA library construction and next generation sequencing. Various quality control checkpoints are described to allow readers to understand what to expect when working with low input samples like exRNAs.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Extracellular vesicles
Background
- This is the first paper addressing technical problems in sequencing small RNAs derived from extracellular vesicles.
- NGS samples require stringent preparation and quality control.
- The QC process of EV samples deviates from the norm.
- The protocol includes QC steps for first-time users.
Purpose of Study
- To provide a reliable method for purifying extracellular microRNAs.
- To facilitate small RNA library construction.
- To enhance next generation sequencing outcomes.
Methods Used
- Plating human mesenchymal stem cells at 2,000 cells per square centimeter.
- Using fresh MSC media in T175 flasks.
- Implementing quality control checkpoints throughout the protocol.
- Demonstrating the procedure by a research assistant.
Main Results
- Successful purification of extracellular microRNAs.
- Establishment of a reliable QC process for EV samples.
- Improved understanding of low input sample handling.
- Facilitation of small RNA library construction for NGS.
Conclusions
- The protocol provides a comprehensive approach to purifying exRNAs.
- Quality control steps are essential for successful sequencing.
- This method can be utilized by first-time users with confidence.
Frequently Asked Questions
What are extracellular microRNAs?
Extracellular microRNAs are small RNA molecules found in the extracellular environment, often involved in intercellular communication.
Why is quality control important in NGS?
Quality control ensures the reliability and reproducibility of sequencing results, especially when working with low input samples.
What cell type is used in this protocol?
Human mesenchymal stem cells are used for the purification of extracellular microRNAs.
How does this protocol differ from standard RNA sequencing?
This protocol includes specific QC steps tailored for extracellular vesicle samples, which differ from standard RNA sequencing procedures.
Can this method be used for other types of RNA?
While this protocol focuses on microRNAs, similar methods can be adapted for other small RNA types.
Who demonstrated the procedure in the video?
The procedure is demonstrated by Junyi Su, a research assistant from the laboratory.
Executive Industry Relevance
Profiling extracellular microRNAs from mesenchymal stem cells enables mechanistic de-risking of paracrine signaling pathways in regenerative medicine and immunomodulation. This protocol supports target validation by linking secreted miRNA cargo to functional phenotypes in disease-relevant systems. Quality-controlled exRNA sequencing provides predictive confidence for biomarker discovery and preclinical model alignment.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogate therapeutic hypotheses by defining the miRNA signature of MSC-derived exosomes.
- Operational Value: Establish a reproducible workflow for isolating low-input exRNAs from conditioned media.
- Predictive Value: Enable functional target validation through correlation of extracellular miRNA profiles with phenotypic outcomes.
Screening & Assay Development
- Scientific Value: Prepare standardized extracellular RNA inputs for downstream screening of modulators of exosome biogenesis.
- Operational Value: Implement QC checkpoints to ensure assay standardization and reproducibility across batches.
- Scalability: Support platform reuse for profiling exRNAs from diverse cell types in disease models.
Translational & Preclinical Research
- Translational Continuity: Connect in vitro MSC exRNA profiles to in vivo biomarker alignment in preclinical disease models.
- Mechanistic De-risking: Clarify pathway involvement of specific miRNAs in immunomodulatory and tissue-repair mechanisms.
- Risk-Adjusted Advancement: Inform go/no-go decisions based on exRNA cargo consistency and functional relevance.
Pipeline & Workflow Integration
This method fits within the discovery continuum from hypothesis testing in early discovery to lead identification and preclinical validation, supported by its focus on extracellular vesicle RNA profiling.
- Discovery Biology: Supports hypothesis testing and pathway clarification by defining the extracellular miRNA landscape of MSCs.
- Screening: Enables assay readiness through standardized exRNA isolation and QC for reliable compound screening.
- Analytics: Generates quantitative length distribution and sequencing outputs that allow comparison of exRNA profiles across conditions.
- Translational Research: Connects to preclinical continuity through disease-relevant exRNA profiling and biomarker alignment potential.
- Enterprise Reuse: Establishes a reusable capability for profiling exRNAs from various stem and progenitor cells in regenerative medicine programs.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation, reduction of mechanistic ambiguity in paracrine signaling.
- Operational Value: Standardization, reproducibility, and scalability of low-input RNA workflows.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk in cell therapy development.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on exRNA biomarker consistency.
Implementation Considerations
- Requires expertise in extracellular vesicle handling and low-input RNA techniques.
- Needs access to ultracentrifugation, nanoparticle tracking analysis, and capillary electrophoresis instrumentation.
- Demands cross-team standardization of media collection, EV isolation, and RNA QC procedures.
- Involves adaptation considerations when applying the protocol to other cell types or biofluids.
- Includes practical limitations such as low RNA yield and contamination risks from serum-derived vesicles, mitigated by rigorous washing and ultracentrifugation steps.
Biopharma FAQs
Why does quality control matter for extracellular RNA sequencing?
Quality control ensures reliable sequencing results by addressing the unique challenges of low-input exRNA samples, such as contamination risks and variable yield, which are critical for reproducible target validation and biomarker discovery.
How does isolating extracellular vesicles support target validation?
Isolating extracellular vesicles enables purification of cell-type-specific miRNA cargo, allowing researchers to link secreted regulatory molecules to functional phenotypes and de-risk therapeutic hypotheses in preclinical models.
What does length distribution analysis reveal about extracellular RNA libraries?
Length distribution analysis identifies enrichment at 22 nucleotides, confirming microRNA presence, while additional peaks indicate tRNA fragments or other small RNA species, informing profile interpretation and assay specificity.
Why are replication requirements important for exRNA profiling workflows?
Replication ensures consistency in exRNA yield and profile across experiments, supporting cross-functional collaboration and confidence in data used for lead identification and preclinical decision-making.
What statistical analysis is needed before implementing exRNA sequencing in discovery pipelines?
Basic quantitative analysis of read mapping, length distribution, and contamination assessment is required to compare extracellular RNA profiles and assess their relevance to target validation and biomarker strategies.
Chapters in this video
0:04
Title
0:33
Cell Culture, and the Collection of EVs and RNA-associated Biomolecules
2:54
RNA Extraction and Quality Control
4:20
Library Construction and Quality Control
9:04
Results: Collecting exRNA from hMSC for Next Generation Sequencing
10:31
Conclusion
